Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 134 institutions that hold shares in the stock, with a total of 84.3 Million shares, which have been reported (via 13F filing form) to have a value of $616 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
570,781
shares
|
$4.17 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.29%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
493,805
shares
|
$3.61 Million
0.0% of portfolio
|
Q2 2025
Reduced 39.19%
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Aug 14, 2025 Q2 2025 |
463,864
shares
|
$3.39 Million
4.3% of portfolio
|
Q2 2025
Added 42.49%
|
|
Walleye Capital LLC
Plymouth, MN |
Aug 13, 2025 Q2 2025 |
376,559
shares
|
$2.75 Million
0.01% of portfolio
|
Q2 2025
Reduced 36.63%
|
|
Schroder Investment Management Group
London, X0 |
Aug 13, 2025 Q2 2025 |
376,204
shares
|
$2.75 Million
0.0% of portfolio
|
Q1 2025
Added 263.45%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
373,247
shares
|
$2.73 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.17%
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Jul 08, 2025 Q2 2025 |
346,850
shares
|
$2.54 Million
0.04% of portfolio
|
Q1 2025
Added 0.04%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
336,665
shares
|
$2.46 Million
0.0% of portfolio
|
Q2 2025
Reduced 51.57%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
335,169
shares
|
$2.45 Million
0.0% of portfolio
|
Q2 2025
Added 4.36%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
326,233
shares
|
$2.38 Million
0.0% of portfolio
|
Q2 2025
Reduced 21.39%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
316,836
shares
|
$2.32 Million
0.0% of portfolio
|
Q2 2025
Added 189.08%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
301,612
shares
|
$2.2 Million
0.01% of portfolio
|
Q1 2025
Reduced 3.21%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
294,195
shares
|
$2.15 Million
0.0% of portfolio
|
Q1 2025
Added 467.62%
|
|
Ubs Oconnor LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
273,619
shares
|
$2 Million
0.05% of portfolio
|
Q2 2025
Reduced 18.6%
|
|
Diadema Partners LP
Morristown, NJ |
Aug 14, 2025 Q2 2025 |
259,852
shares
|
$1.9 Million
0.3% of portfolio
|
Q2 2025
Added 363.21%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
244,637
shares
|
$1.79 Million
0.0% of portfolio
|
Q2 2025
Reduced 62.54%
|
|
Lpl Financial LLC
Fort Mill, SC |
Aug 12, 2025 Q2 2025 |
241,825
shares
|
$1.77 Million
0.0% of portfolio
|
Q2 2025
Added 0.52%
|
|
Exchange Traded Concepts, LLC
|
Jul 10, 2025 Q2 2025 |
227,847
shares
|
$1.67 Million
0.01% of portfolio
|
Q2 2025
Added 65.51%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
224,220
shares
|
$1.64 Million
0.0% of portfolio
|
Q2 2025
Added 8.61%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
204,957
shares
|
$1.5 Million
0.0% of portfolio
|
Q2 2025
Added 60.79%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
202,570
shares
|
$1.48 Million
0.0% of portfolio
|
Q2 2025
Reduced 59.07%
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
202,348
shares
|
$1.48 Million
0.32% of portfolio
|
Q1 2023
New holding
|
|
Infinitum Asset Management, LLC
Fort Lauderdale, FL |
Aug 13, 2025 Q2 2025 |
200,000
shares
|
$1.46 Million
0.17% of portfolio
|
Q1 2025
Reduced 63.77%
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
194,345
shares
|
$1.42 Million
0.0% of portfolio
|
Q2 2025
Added 3353.18%
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
129,668
shares
|
$947,873
0.0% of portfolio
|
Q2 2025
Added 13.99%
|